Aims: Understanding the underlying molecular mechanisms involved in epileptogenesis is necessary to target the best therapeutic interventions in epilepsy. Recently, it has been postulated that metformin, an old antidiabetic oral drug, has anti-seizure properties mostly due to its antioxidant activities. This study was designed to evaluate the ameliorative effects of metformin on the progression of epilepsy in the temporal lobe epilepsy model in rats. Main methods: Temporal lobe Epilepsy was induced by intracerebroventricular microinjection of kainic acid. Metformin was orally administered for two weeks before induction of epilepsy. Anti-epileptogenic activity of metformin was evaluated by intracranial electroencepholography (IEEG) recording...
Metformin, a well-known antidiabetic drug, has recently been proposed to promote neurogenesis and to...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...
Aims: Understanding the underlying molecular mechanisms involved in epileptogenesis is necessary to ...
Background. Epilepsy is one of the common neurological illnesses which affects millions of individua...
Temporal lobe epilepsy (TLE) is a common form of drug-resistant epilepsy that sometimes responds to ...
Temporal lobe epilepsy (TLE) is a common form of drug-resistant epilepsy that sometimes responds to ...
17 páginas, 2 figurasMetformin is a drug in the family of biguanide compounds that is widely used in...
AbstractCaloric restriction (CR) has anti-epileptic effects in different animal models, at least par...
Metformin is currently used as a first-line drug to treat patients with type 2 diabetes. Previous st...
Introduction: Metformin is currently first line therapy for type 2 diabetes (T2D). The mechanism of ...
Purpose: It has been shown that blood-brain barrier leakage together with inflammation could contrib...
Introduction: Studies have indicated that metformine has different effects on learning and memory. I...
Abstract Metformin (Met) is a commonly used drug in the treatment of type 2 diabetes. Currently, it ...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...
Metformin, a well-known antidiabetic drug, has recently been proposed to promote neurogenesis and to...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...
Aims: Understanding the underlying molecular mechanisms involved in epileptogenesis is necessary to ...
Background. Epilepsy is one of the common neurological illnesses which affects millions of individua...
Temporal lobe epilepsy (TLE) is a common form of drug-resistant epilepsy that sometimes responds to ...
Temporal lobe epilepsy (TLE) is a common form of drug-resistant epilepsy that sometimes responds to ...
17 páginas, 2 figurasMetformin is a drug in the family of biguanide compounds that is widely used in...
AbstractCaloric restriction (CR) has anti-epileptic effects in different animal models, at least par...
Metformin is currently used as a first-line drug to treat patients with type 2 diabetes. Previous st...
Introduction: Metformin is currently first line therapy for type 2 diabetes (T2D). The mechanism of ...
Purpose: It has been shown that blood-brain barrier leakage together with inflammation could contrib...
Introduction: Studies have indicated that metformine has different effects on learning and memory. I...
Abstract Metformin (Met) is a commonly used drug in the treatment of type 2 diabetes. Currently, it ...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...
Metformin, a well-known antidiabetic drug, has recently been proposed to promote neurogenesis and to...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...